“…Several studies have demonstrated possible beneficial effects of anthocyanins on chronic degenerative diseases, including CVD and cancer (Tsuda et al, 1996;Prior and Cao, 2000;Kay and Holub, 2002;Nakamura et al, 2002;Hou, 2003;Kang et al, 2003;Xu et al, 2004;Rechner and Kroner, 2005;Dalgard et al, 2009). Anthocyanins have low bioavailability (Kay, 2006;Hollands et al, 2008) and are metabolised in humans into methylated derivatives, glucuronides and sulfoconjugates (Wu et al, 2002;Felgines et al, 2003Felgines et al, , 2005Kay et al, 2004Kay et al, , 2005, but phenolic acids are the major stable metabolites of anthocyanins in vivo (Keppler and Humpf, 2005;Fleschhut et al, 2006). Endothelial cell dysfunction is a critical initiating event in the progression of atherosclerosis (Ross, 1999), but the effects of anthocyanins on endothelial function at normal intake levels have not been reported previously.…”